| Remyelination is altered by bone morphogenic protein signaling in demyelinated lesions JK Sabo, TD Aumann, D Merlo, TJ Kilpatrick, HS Cate Journal of Neuroscience 31 (12), 4504-4510, 2011 | 96 | 2011 |
| Modulation of bone morphogenic protein signalling alters numbers of astrocytes and oligodendroglia in the subventricular zone during cuprizone‐induced demyelination HS Cate, JK Sabo, D Merlo, D Kemper, TD Aumann, J Robinson, ... Journal of neurochemistry 115 (1), 11-22, 2010 | 83 | 2010 |
| 3D Electrospun scaffolds promote a cytotrophic phenotype of cultured primary astrocytes CL Lau, M Kovacevic, TS Tingleff, JS Forsythe, HS Cate, D Merlo, ... Journal of neurochemistry 130 (2), 215-226, 2014 | 63 | 2014 |
| Transcriptomic profiling of astrocytes treated with the Rho kinase inhibitor Fasudil reveals cytoskeletal and pro‐survival responses CL Lau, VM Perreau, MJ Chen, HS Cate, D Merlo, NS Cheung, ... Journal of cellular physiology 227 (3), 1199-1211, 2012 | 57 | 2012 |
| Common and low frequency variants in MERTK are independently associated with multiple sclerosis susceptibility with discordant association dependent upon HLA-DRB1* 15: 01 status MD Binder, AD Fox, D Merlo, LJ Johnson, L Giuffrida, SE Calvert, ... PLoS genetics 12 (3), e1005853, 2016 | 46 | 2016 |
| Monitoring cognitive change in multiple sclerosis using a computerized cognitive battery L De Meijer, D Merlo, O Skibina, EJ Grobbee, J Gale, J Haartsen, P Maruff, ... Multiple Sclerosis Journal–Experimental, Translational and Clinical 4 (4 …, 2018 | 24 | 2018 |
| The feasibility, reliability and concurrent validity of the MSReactor computerized cognitive screening tool in multiple sclerosis D Merlo, D Darby, T Kalincik, H Butzkueven, A van der Walt Therapeutic advances in neurological disorders 12, 1756286419859183, 2019 | 20 | 2019 |
| Comparison between dimethyl fumarate, fingolimod, and ocrelizumab after natalizumab cessation C Zhu, T Kalincik, D Horakova, Z Zhou, K Buzzard, O Skibina, ... JAMA neurology 80 (7), 739-748, 2023 | 16 | 2023 |
| Inhibiting bone morphogenetic protein 4 type I receptor signaling promotes remyelination by potentiating oligodendrocyte differentiation AE Govier-Cole, RJ Wood, JL Fletcher, DG Gonsalvez, D Merlo, HS Cate, ... Eneuro 6 (2), 2019 | 14 | 2019 |
| Comparing switch to ocrelizumab, cladribine or natalizumab after fingolimod treatment cessation in multiple sclerosis C Zhu, Z Zhou, I Roos, D Merlo, T Kalincik, S Ozakbas, O Skibina, J Kuhle, ... Journal of Neurology, Neurosurgery & Psychiatry 93 (12), 1330-1337, 2022 | 9 | 2022 |
| Association between cognitive trajectories and disability progression in patients with relapsing-remitting multiple sclerosis D Merlo, J Stankovich, C Bai, T Kalincik, C Zhu, M Gresle, J Lechner-Scott, ... Neurology 97 (20), e2020-e2031, 2021 | 9 | 2021 |
| Subjective versus objective performance in people with multiple sclerosis using the MSReactor computerised cognitive tests. D Merlo, T Kalincik, C Zhu, M Gresle, J Lechner-Scott, T Kilpatrick, ... Multiple sclerosis and related disorders 58, 103393, 2022 | 6 | 2022 |
| Smartphone monitoring of cognition in people with multiple sclerosis: A systematic review YC Foong, F Bridge, D Merlo, M Gresle, C Zhu, K Buzzard, H Butzkueven, ... Multiple sclerosis and related disorders 73, 104674, 2023 | 5 | 2023 |
| Influence of methylprednisolone on magnetic resonance and histological measures during cuprizone-induced demyelination HS Cate, QZ Wu, D Kemper, D Merlo, HX Wang, K Fang, GF Egan, ... Neuroscience letters 483 (1), 47-52, 2010 | 5 | 2010 |
| Comparing ocrelizumab to interferon/glatiramer acetate in people with multiple sclerosis over age 60 YC Foong, D Merlo, M Gresle, K Buzzard, M Zhong, WZ Yeh, V Jokubaitis, ... Journal of Neurology, Neurosurgery & Psychiatry, 2024 | 3 | 2024 |
| The Patient‐Determined Disease Steps scale is not interchangeable with the Expanded Disease Status Scale in mild to moderate multiple sclerosis YC Foong, D Merlo, M Gresle, C Zhu, K Buzzard, J Lechner‐Scott, ... European journal of neurology 31 (1), e16046, 2024 | 3 | 2024 |
| The MSReactor computerized cognitive battery correlates with the processing speed test in relapsing-remitting multiple sclerosis C Yam, D Merlo, J Stankovich, D Darby, M Gresle, T Kalincik, TJ Kilpatrick, ... Multiple Sclerosis and Related Disorders 43, 102212, 2020 | 2 | 2020 |
| A prospective study of the feasibility of smartphone-based self-monitoring to characterise cognitive and neurological impairment in people with multiple sclerosis: Floodlight … A van der Walt, H Butzkueven, M Barnett, D Darby, X Denos, ... Mult Scler 28 (3 Supplement), 2022 | 1 | 2022 |
| The impact of location, time and practice effects on computerised cognitive testing using msreactor in people with multiple sclerosis A Van der Walt, D Merlo, T Kalincik, J Haartsen, DG Darby, H Butzkueven Journal of Neurology, Neurosurgery & Psychiatry 88 (5), e1-e1, 2017 | 1 | 2017 |
| 3115 Longitudinal trajectories of digital cognitive biomarkers for multiple sclerosis YC Foong, D Merlo, M Gresle, C Zhu, K Buzzard, J Lechner-Scott, ... BMJ Neurology Open 6 (Suppl 1), 2024 | | 2024 |
